EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Human monocyte cyto toxicity to tumor cells part 1 antibody dependent cyto toxicity



Human monocyte cyto toxicity to tumor cells part 1 antibody dependent cyto toxicity



Journal of Immunology 121(2): 573-578



Recent investigations examining mononuclear cell antibody-dependent cell-mediated cytotoxicity against tumor cell lines suggest that K [antibody dependent cytotoxic] lymphocytes and not monocytes are active in this cytotoxic reaction. It was found, however, that in an allogeneic assay system, human monocyte monolayers and lymphocytes mediate substantial lysis of 51Cr-labeled antibody-coated CEM [human] lymphoblast tumor cells. This cytotoxicity is temperature-dependent and rapid, with most 51Cr release occurring in the first 4 h of co-incubation. Interaction between target cell-bound antibody and the monocyte Fc receptor is necessary as demonstrated by the marked fall in antibody-dependent cell-mediated cytotoxicity (ADCC) produced by staphylococcal protein A, high concentrations of nonspecific immunoglobulin and dilution of the target cell antiserum. Morphologic and functional characteristics of the monocyte-monolayer preparations establish their relative purity (> 95%) and indicate that monocytes and not contaminating lymphocytes are responsible for tumor cell lysis. Preincubation of monocyte and lymphocyte preparations with latex particles or low concentrations of immunoglobulin distinguished monocyte from lymphocyte ADCC. Thus, normal human monocytes have the capacity to carry out antibody-dependent cytotoxicity against nucleated malignant target cells.

(PDF emailed within 1 workday: $29.90)

Accession: 005593541

Download citation: RISBibTeXText



Related references

Antibody dependent cellular cyto toxicity against tumor cells part 2 the pro monocyte identified as effector cell. European Journal of Immunology 9(4): 267-272, 1979

Comparison between monocyte antibody dependent cyto toxicity and lymphocyte antibody dependent cyto toxicity in immuno therapy treated and untreated melanoma patients. Proceedings Of The American Association For Cancer Research & American Society Of Clinical Oncology: 8, 1981

Natural cyto toxicity and antibody dependent cyto toxicity in solid tumor cancer patients regulation by adherent cells. Clinical Immunology & Immunopathology 23(1): 133-144, 1982

Effector cells for antibody dependent cell mediated cyto toxicity part 1 increased cyto toxicity after priming with bcg aqueous extract. Cellular Immunology 29(2): 373-381, 1977

Human monocyte lymphocyte and granulocyte antibody dependent cell mediated cyto toxicity to tumor cells. Clinical Research 26(5): 686A, 1978

Simultaneous expression of cell mediated cyto toxicity and antibody dependent cellular cyto toxicity to a syngeneic rat lymphoma separation and partial characterization of 2 types of cyto toxic cells. Cellular Immunology 14(2): 193-205, 1974

Human natural cell mediated cyto toxicity against fetal fibroblasts part 4 comparison of cyto toxic activity with antibody dependent cell mediated cyto toxicity. Scandinavian Journal of Immunology 9(3): 239-246, 1979

Cyto toxicity from cultured cells analysis of precursors involved in generation of human cells mediating natural and antibody dependent cell mediated cyto toxicity. Cellular Immunology 48(2): 356-368, 1979

Human monocyte lymphocyte and granulocyte antibody dependent cell mediated cyto toxicity toward tumor cells 1. characteristics of cytolysis. Journal of Immunology 123(2): 594-599, 1979

Spontaneous cyto toxicity part 3 inhibition of human monocyte mediated cyto toxicity by pokeweed mitogen. Journal of Immunology 122(1): 61-64, 1979

Examination of tumor cell immuno resistance by complement dependent cyto toxicity and antibody dependent cellular cyto toxicity. Federation Proceedings 37(6): 1381, 1978

Study of antibody dependent cellular cyto toxicity part 1 lymphocyte mediated cyto toxicity by lymphocytes from healthy individuals. Archivum Immunologiae et Therapiae Experimentalis 26(1-6): 307-310, 1978

Langerhans cell containing epidermal cells are not cyto toxic in antibody dependent cellular cyto toxicity and mitogen induced cellular cyto toxicity. Immunobiology 162(3): 229-236, 1982

Temporal differences in the maintenance of antibody dependent cellular cyto toxicity and of direct tumor cyto toxicity expressed by macrophages in culture. RES Journal of the Reticuloendothelial Society 24(SUPPL): 52A, 1978